SHPH
Shuttle Pharmaceuticals IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$4.19M
P/E Ratio
—
EPS
$-7.18
Beta
0.72
52W High
$12.32
52W Low
$0.50
50-Day MA
$1.19
200-Day MA
$2.58
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Shuttle Pharmaceuticals Inc
Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development and commercialization of drugs to sensitize cancers to radiation therapy. The company is headquartered in Rockville, Maryland.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-11.63M |
| Operating Margin | 0.00% |
| Return on Equity | -791.00% |
| Return on Assets | -114.70% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $1.13 |
| Price-to-Book | 1.88 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -0.67 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $5.59M |
| Float | $5.56M |
| % Insiders | 0.94% |
| % Institutions | 3.09% |
Data last updated: 4/9/2026